Aragen Life Sciences has appointed Manav Kataria as Director, Business Development – Enterprise Accounts, where he will support the growth of the company’s Development & Manufacturing (D&M) business.

Kataria brings more than 15 years of experience across the pharmaceutical CDMO and life sciences sectors, with expertise in business development, strategic partnerships, client engagement and commercial growth across the drug development lifecycle.

In his new role, he will focus on strengthening relationships with key global customers and driving growth across enterprise accounts, leveraging his experience in building strategic partnerships and expanding business opportunities.

Prior to joining Aragen, Kataria held leadership roles in business development, presales and business management at Jubilant Ingrevia Limited, adding to his experience in commercial strategy and customer engagement within the life sciences industry.

His appointment comes as Aragen continues to expand its global Development & Manufacturing business and deepen partnerships with pharmaceutical and biotechnology companies.